Next Article in Journal
5(S)-((3aR,4R,6aR)-2,2-Dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-2-phenyl-4,5-dihydrooxazole
Previous Article in Journal
Structural Elucidation of a New Puzzling Compound Emerged from Doebner Quinoline Synthesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene

by
Vladislav V. Komarov
,
Vyacheslav I. Krasnov
,
Victor M. Karpov
,
Dmitriy A. Parkhomenko
* and
Tatyana V. Mezhenkova
*
N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev Ave. 9, Novosibirsk 630090, Russia
*
Authors to whom correspondence should be addressed.
Molbank 2024, 2024(3), M1842; https://doi.org/10.3390/M1842
Submission received: 6 June 2024 / Revised: 19 June 2024 / Accepted: 20 June 2024 / Published: 25 June 2024
(This article belongs to the Section Organic Synthesis)

Abstract

:
The title compound was synthesized from perfluoro-1-ethyltetralin and 1,2,3,4-tetrafluorobenzene under the action of antimony pentafluoride as a mixture of cis- and trans-isomers in a 71% isolated yield. The structure and cis-/trans-configuration of the isomers were determined by NMR (19F, 13C), 19F–19F COSY, and 19F–19F NOESY 2D NMR spectroscopy.

1. Introduction

Organofluorine compounds are receiving increasing attention in terms of basic research in organic chemistry as well as finding application in materials science, biomedicine, and agriculture [1,2,3,4,5,6,7,8,9]. In particular, fluorine-containing fluorenes are regarded as promising objects for optoelectronics [10,11,12,13], catalysis [14,15,16], and have even found success as drugs approved for medical use [17]. With the polyfluorinated species of this class of compounds being represented by only a handful of examples [11,18,19,20], further research on their useful properties and application is still impeded.
Previously, we studied the reactions of perfluoroalkylbenzenes with polyfluorobenzenes leading to polyfluorinated 9-alkylfluorenes [21,22,23]. Then, we showed that perfluorotetralin—a cyclic analog of perfluoroalkylbenzenes—reacted with 1,2,3,4-tetrafluorobenzene in the presence of antimony pentafluoride to produce perfluoro-1,2,3,10b-tetrahydrofluoranthene containing a fluorene motif in the molecule [24]. The present study focuses on the synthesis of a 3-ethyl derivative of perfluoro-1,2,3,10b-tetrahydrofluoranthene and its unambiguous characterization.

2. Results and Discussion

The interaction of perfluoro-1-ethyltetralin (1) with 1,2,3,4-tetrafluorobenzene (2) in the presence of antimony pentafluoride at 50 °C for 30 h, followed by treating the reaction mixture with HF–Py and then with water, yielded perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene (3) as a mixture of cis- and trans-isomers in an approximately equal ratio (Scheme 1). The separation of the individual isomers proved to be a difficult task. After the reaction mixture was subjected to column chromatography, only small amounts of individual isomers were isolated, with the major fraction being a mixture of the isomers. The total isolated yield was 71%.
Similar to the formation of parent perfluoro-1,2,3,10b-tetrahydrofluoranthene [24], the formation of compound 3 seems to proceed as follows. Tetralin 1 reacts with tetrafluorobenzene 2 in the presence of SbF5 to form an intermediate compound A. The latter, under the action of antimony pentafluoride, generates cation A+, which undergoes intramolecular cyclization, with the loss of a proton, to yield intermediate B. In the SbF5 medium, compound B transforms into cation B+. The subsequent addition of a fluorine anion to cation B+ during HF–Py work-up results in product 3 as a mixture of two stereoisomers (Scheme 2).
The structure of compound 3 was established by 19F, 13C, and 2D NMR spectroscopy and HRMS. In the 19F NMR spectra, the isomers have close chemical shifts for respective nuclei, the most profound difference being in the shifts of F3. The chemical shifts and splitting of the signals are in conformity with the patterns observed for the parent perfluoro-1,2,3,10b-tetrahydrofluoranthene [24]. Nevertheless, these data were not enough to establish the cis-/trans-configurations of the two isomers and resolve the ambiguity in assigning the signals of tertiary F3 and F10b. For that, a series of additional 2D NMR spectra (19F–19F COSY and 19F–19F NOESY) were obtained. In the COSY spectrum of trans-3 (Figure 1), we observed correlations between F3 and F4 as well as between F3 and CF3. We also observed a weak correlation between F10b and F10 alongside a strong cross peak of F10b with CF2-1. These findings validate the assignment of the tertiary fluorine atoms F3 and F10b. Both the COSY and NOESY spectra of trans-3 (Figure 1) showed a significant correlation between F10b and the CF2 moiety of the CF2CF3 group that can only be if trans-3 indeed has trans-configuration. The other correlations observed in both spectra corresponded with the assignment of all the signals.
In the case of cis-3, a similar analysis was performed to assign the tertiary fluorine atoms. The COSY spectrum did not seem to have cross peaks of the tertiary fluorine atoms with the aromatic F4 and F10, instead showing a correlation between F3 and the CF2CF3 group, whereas F10b had a cross peak with CF2-1. The COSY and NOESY spectra of the isomer showed no cross peaks between F10b and the CF2 moiety of the CF2CF3 group, thereby clearly indicating the cis-arrangement of the tertiary fluorine atoms. Both spectra also showed F3–F10b cross peaks (Figure 2).
It is noteworthy that the signals of the tertiary fluorine atoms in cis-3 were unresolved and rather broadened, arguably because of the conformational transitions of the alicyclic moiety. Therefore, a series of variable-temperature 19F NMR experiments were conducted. In a CDCl3 solution, the signals had a chemical shift difference of ca. 1 ppm at 298 K. With increasing temperature, the signals started to appear as doublets of an AB system (JAB ≈ 40 Hz) and shift toward each other, degrading into what appeared like a single peak at 325 K. To obtain a better picture, we switched to another solvent. In a DMSO-d6 solution, the difference in the tertiary fluorine chemical shifts exceeded 4 ppm at the ambient temperature, and the AB system became more obvious. With increasing temperature, the signals also shifted toward each other, became narrower, and splitting patterns emerged (Figure 3). This 5JFF ≈ 40 Hz constant between F3 and F10b confirmed their cis-arrangement because it can only arise from through-space fluorine–fluorine coupling.
The 13C spectra of the individual isomers revealed seven aromatic carbons along with two tertiary C, five quaternary C, and a CF3 group; the signals due to CF2 carbons are located in the δC 108–113 region, have rather complex splitting patterns, and, with the signal components overlapping, their further analysis appeared to be superfluous since it yields little additional information on the structural characteristics.

3. Materials and Methods

3.1. General Information

19F spectra were recorded on a Bruker AV 400 (Bruker Corporation, Billerica, MA, USA) instrument (376.5 MHz), variable-temperature 19F NMR experiments were conducted on a Bruker AV 300 instrument (282.4 MHz), and 13C NMR spectra were recorded on a Bruker AV 600 (150.92 MHz) instrument. Chemical shifts (δ) are reported in ppm relative to CCl3F (19F, upfield negative) and TMS (13C); C6F6F = −162.9 ppm) and CDCl3C = 76.9 ppm) served as internal standards. Coupling constants (J) are reported in Hz and rounded to the nearest 0.5 Hz. The following abbreviations were used to designate multiplicities: d = doublet, t = triplet, q = quartet, and m = multiplet.
2D NMR experiments were performed on a Bruker AV400 spectrometer, equipped with a 5 mm z-axis field-gradient probehead. Bruker programs for pulse sequence were used. Typical parameters for 2D NMR experiments were as follows. FID data were processed with zero-filling and sine-bell function weighting applied prior to Fourier transformation in order for the resolution to be optimized appropriately.
19F–19F COSY: cosygpqf—pulse program, gradient pulses for selection were used, 8K x 1024 time-domain data matrix, 1 scan for each FID with a relaxation time of 3 s.
19F–19F NOESY: noesygpph—pulse program, States-TPPI (time-proportional phase incrementation) acquisition mode, 800 ms mixing time, 8K × 512 time-domain data matrix, 2 scans for each FID with a relaxation time of 2 s.
Molecular masses of the compounds were determined by HRMS with a Thermo Electron Corporation DFS (Thermo Fisher Scientific, Waltham, MA, USA) instrument (EI 70 eV). Column chromatography was carried out on Silica gel 60 (Merck KGaA, Darmstadt, Germany, particle size 0.063–0.200 mm).
Contents of products in the reaction mixture were determined by 19F NMR integration versus pentafluorobenzoic acid. For that, a 19F NMR spectrum was acquired using zgflqn pulse program. The relaxation delay (D1) was 10 s to take into account differential relaxation times. The FID was multiplied by an exponential weighting (lb  =  0.5 Hz) and zero-filled to 256k data points before Fourier transformation; phase and baseline correction were performed manually prior to integration.
Antimony pentafluoride was distilled under atmospheric pressure (bp 142–143 °C). 1,2,3,4-Tetrafluorobenzene was purchased from commercial sources (>98% purity) and used as received. Perfluoro-1-ethyltettralin was synthesized according to the literature procedure [25].

3.2. Synthesis of Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene

Into a nickel container, SbF5 (5.27 g, 24.31 mmol) and compound 1 (1.82 g, 4.06 mmol) were placed, then tetrafluorobenzene 2 (0.61 g, 4.07 mmol) was added dropwise at 0 °C. The mixture was properly stirred and heated at 50 °C for 30 h. The resultant mixture was treated with HF–Py (6.0 mL) at −15 °C and kept for 4 h with occasional shaking, then cooled down to −15 °C and poured onto ice, extracted with CHCl3, and the extract was dried over MgSO4. After filtration, the solvent was removed under reduced pressure to afford 2.29 g of a crude reaction mixture containing 76% of compound 3 as a mixture of cis- and trans-isomers in a 51 : 49 molar ratio (19F NMR). Column chromatography (hexane as the eluent) yielded 50 mg of compound trans-3, 40 mg of compound cis-3, and 1.52 g of a mixture of isomers in an approximately 1:1 ratio (71% total isolated yield).
Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene (Figure 4)
Trans-isomer. Colorless liquid. 19F NMR (376.5 MHz, CDCl3): δ −79.0 (m, 3F, CF3), −110.9 (dm, 1FA2, CF2-2) and −121.5 (dm, 1FB2, CF2-2), −115.6 (dm, 1FA3, CF2CF3) and −116.7 (dm, 1FB3, CF2CF3), −120.3 (dm, 1FA1, CF2-1) and −131.5 (ddm, 1FB1, CF2-1), −120.8 (ddd, 1F, F-6), −124.1 (m, 1F, F-4), −132.9 (dddd, 1F, F-7), −133.5 (dddd, 1F, F-10), −145.5 (dddd, 1F, F-8), −146.7 (ddd, 1F, F-5), −149.7 (ddd, 1F, F-9), −157.9 (m, 1F, F-10b), −168.6 (m, 1F, F-3); JA1,B1 = 261, JA2,B2 = 278, JA3,B3 = 290, JB1,10 = 42, J4,5 = 17, J4,6 = 16, J5,6 = 19, J5,10b = 4, J6,7 = 59, J7,8 = 20, J7,9 = 5, J7,10 = 15, J8,9 = 18, J8,10 = 8, J8,10b = 4, J9,10 = 21.
13C NMR (150.92 MHz, CDCl3): δ 151.4 (dd, 1JCF = 273, 2JCF = 13.5) and 148.5 (dd, 1JCF = 272, 2JCF = 13, C-4, C-10), 145.9 (dd, 1JCF = 262, 2JCF = 12.5) and 142.7 (dd, 1JCF = 261, 2JCF = 13, C-6, C-7), 144.9 (dt, 1JCF = 262, 2JCF = 15.5) and 144.7 (dt, 1JCF = 261, 2JCF = 14.5, C-5, C-8), 142.1 (dt, 1JCF = 262, 2JCF = 14.5, C-9), 131.0 (dm, 2JCF ~ 15, C-3a1), 120.5 (d, 2JCF = 14.5) and 119.7 (d, 2JCF = 15.5, C-6a, C-6b), 117.9 (qt, 1JCF = 288, 2JCF = 34, CF3), 117.0 (t, 2JCF = 18, C-10a), ~112.6 (m, C-3a), ~108.7–113.5 (m, C-1, C-2, CF2CF3), 92.6 (dtdd, 1JCF = 218, 2JCF = 29, 2JCF = 29, 2JCF = 22, C-3), 92.4 (ddd, 1JCF = 200, 2JCF = 35, 2JCF = 25, C-10b).
HRMS (EI) m/z: calcd. for C18F18 557.9707; found 557.9712.
Cis-isomer. Colorless liquid. 19F NMR (376.5 MHz, CDCl3): δ −79.4 (m, 3F, CF3), −112.9 (dm, 1FA, CF2-2) and −121.7 (dm, 1FB, CF2-2), −114.0 (dm, 1FA, CF2CF3) and −117.4 (dm, 1FB, CF2CF3), −118.8 (dm, 1FA, CF2-1) and −124.2 (ddm, 1FB, CF2-1), −120.0 (m, 1F, F-4), −120.2 (ddd, 1F, F-6), −132.7 (dddd, 1F, F-7), −134.0 (dddd, 1F, F-10), −145.9 (dddd, 1F, F-8), −146.1 (ddd, 1F, F-5), −149.7 (ddd, 1F, F-9), −152.3 (m, 1F, F-3), −153.5 (m, 1F, F-10b); JA1,B1 = 259, JA2,B2 = 275, JA,B(CF2CF3) = 293, JB1,10 = 39, J4,5 = 16.5, J4,6 = 17, J5,6 = 20, J5,10b = 4, J6,7 = 59, J7,8 = 21, J7,9 = 5, J7,10 = 15, J8,9 = 17, J8,10 = 8, J8,10b = 4, J9,10 = 20.5.
13C NMR (150.92 MHz, CDCl3): δ 150.4 (dd, 1JCF = 274, 2JCF = 14) and 148.6 (dd, 1JCF = 273, 2JCF = 12.5, C-4, C-10), 145.5 (dd, 1JCF = 262, 2JCF = 13) and 142.7 (dd, 1JCF = 261, 2JCF = 13.5, C-6, C-7), 144.9 (dt, 1JCF = 262, 2JCF = 16.5) and 144.6 (dt, 1JCF = 261, 2JCF = 15, C-5, C-8), 142.2 (dt, 1JCF = 261, 2JCF = 14.5, C-9), 132.8 (d, 2JCF = 16, C-3a1), 121.5 (d, 2JCF = 14.5) and 119.4 (d, 2JCF = 15.5, C-6a, C-6b), 118.0 (qt, 1JCF = 289, 2JCF = 34, CF3), 117.4 (t, 2JCF = 17.5, C-10a), ~108.5–114.3 (m, C-1, C-2, CF2CF3), ~112.3 (m, C-3a), 92.9 (ddd, 1JCF = 200, 2JCF = 35.5, 2JCF = 25.5, C-10b), 90.7 (dtt, 1JCF = 215, 2JCF ~ 27, 2JCF ~ 27, C-3).
HRMS (EI) m/z: calcd. for C18F18 557.9707; found 557.9706.

Supplementary Materials

Figures S1–S5: HRMS, 19F, 13C NMR, and 19F-19F COSY, 19F-19F NOESY spectra for compound trans-3; Figures S6–S10: HRMS, 19F, 13C NMR, and 19F-19F COSY, 19F-19F NOESY spectra for compound cis-3.

Author Contributions

Conceptualization, V.M.K. and T.V.M.; methodology, V.I.K., T.V.M., and V.M.K.; formal analysis, V.V.K. and V.I.K.; investigation, V.V.K. and V.I.K.; writing—original draft preparation, V.V.K.; writing—review and editing, T.V.M. and D.A.P.; visualization, V.V.K. and D.A.P.; supervision, T.V.M.; project administration, T.V.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

All data are included in the manuscript and the Supplementary Materials.

Acknowledgments

The authors are grateful to the Multi-Access Chemical Research Center of SB RAS for spectral and analytical measurements.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kirsch, P. Modern Fluoroorganic Chemistry. In Synthesis, Reactivity, Applications; Wiley-VCH: Weinheim, Germany, 2013. [Google Scholar]
  2. Purser, S.; Moore, P.R.; Swallow, S.; Gouverneur, V. Fluorine in medicinal chemistry. Chem. Soc. Rev. 2008, 37, 320–330. [Google Scholar] [CrossRef] [PubMed]
  3. Politanskaya, L.V.; Selivanova, G.A.; Panteleeva, E.V.; Tretyakov, E.V.; Platonov, V.E.; Nikul’shin, P.V.; Vinogradov, A.S.; Zonov, Y.V.; Karpov, V.M.; Mezhenkova, T.V.; et al. Organofluorine chemistry: Promising growth areas and challenges. Russ. Chem. Rev. 2019, 88, 425–569. [Google Scholar] [CrossRef]
  4. Hiyama, T. Organofluorine Compounds; Yamamoto, H., Ed.; Springer: Berlin/Heidelberg, Germany, 2000; ISBN 978-3-642-08596-3. [Google Scholar]
  5. Reddy, V.P. Organofluorine Chemistry Synthesis and Applications; Elsevier: Amsterdam, The Netherlands, 2020; ISBN 9780128132869. [Google Scholar]
  6. Babudri, F.; Farinola, G.M.; Naso, F.; Ragni, R. Fluorinated organic materials for electronic and optoelectronic applications: The role of the fluorine atom. Chem. Commun. 2007, 1003–1022. [Google Scholar] [CrossRef] [PubMed]
  7. Han, J.; Remete, A.M.; Dobson, L.S.; Kiss, L.; Izawa, K.; Moriwaki, H.; Soloshonok, V.A.; O’Hagan, D. Next generation organofluorine containing blockbuster drugs. J. Fluor. Chem. 2020, 239, 109639. [Google Scholar] [CrossRef]
  8. Kothapalli, Y.; Jones, R.A.; Chu, C.K.; Singh, U.S. Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties. Molecules 2024, 29, 2390. [Google Scholar] [CrossRef] [PubMed]
  9. O’Hagan, D. The Emergence and Properties of Selectively Fluorinated ‘Janus’ Cyclohexanes. Chem. Rec. 2023, 23, e202300027. [Google Scholar] [CrossRef] [PubMed]
  10. Keshtov, M.L.; Konstantinov, I.O.; Krayushkin, M.M.; Kuklin, S.A.; Masoud, S.M.; Osipov, S.N.; Khokhlov, A.R. New electron-accepting quinoxalinothiadiazole-containing heterocycles as promising building blocks for organic optoelectronic devices. Dokl. Chem. 2016, 468, 202–207. [Google Scholar] [CrossRef]
  11. Ohkubo, K.; Sakamoto, Y.; Suzuki, T.; Tsuzuki, T.; Kumaki, D.; Tokito, S. Synthesis, structure, and transport property of perfluorinated oligofluorenes. Chem.-A Eur. J. 2008, 14, 4472–4474. [Google Scholar] [CrossRef] [PubMed]
  12. Inagi, S.; Yamaguchi, T.; Hayashi, S.; Koseki, K.; Fuchigami, T. Electropolymerization of 9,9-difluorofluorene in BF3-OEt2 toward a photostable n-type material. Electrochem. Commun. 2010, 12, 661–663. [Google Scholar] [CrossRef]
  13. Ma, G.; Zhao, H.; Wang, J.; Le, Y.; Jiang, H.; Deng, H.; Hao, J.; Wan, W. Studies of fluorine auxochrome in C9-fluorenyl anthracenes on optoelectronic property for blue electroluminescent materials. Dye. Pigment. 2018, 158, 420–427. [Google Scholar] [CrossRef]
  14. Calderazzo, F.; Masi, F.; Pampaloni, G.; Passarelli, V.; Santi, R.; Sommazzi, A.; Spera, S.; Tumminia, F. Perfluorofluorenyl anions and their use as co-catalysts in the zirconocene-promoted polymerization of olefins. J. Organomet. Chem. 2005, 690, 4886–4898. [Google Scholar] [CrossRef]
  15. Marks, T.J.; Chen, Y.-X. Organo-Lewis Acids of Enhanced Utility, Uses Thereof, and Products Based Thereon. U.S. Patent 6291695B1, 18 September 2001. [Google Scholar]
  16. Sommazi, A.; Masi, F.; Borsotti, G.; Proto, A.; Santi, R. Activating Composition of Metallocene Complexes in the Catalysis of (Co)Polymerization Processes of Olefins. U.S. Patent 6596891B1, 22 July 2003. [Google Scholar]
  17. Link, J.O.; Taylor, J.G.; Xu, L.; Mitchell, M.; Guo, H.; Liu, H.; Kato, D.; Kirschberg, T.; Sun, J.; Squires, N.; et al. Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection. J. Med. Chem. 2014, 57, 2033–2046. [Google Scholar] [CrossRef] [PubMed]
  18. Filler, R.; Fiebig, A.E.; Pelister, M.Y. Fluorocarbanion Chemistry. Octafluorofluorene and Companions. J. Org. Chem. 1980, 45, 1290–1295. [Google Scholar] [CrossRef]
  19. Pozdnyakovich, Y.V.; Shteingarts, V.D. Fluorine-containing carbocations. XVII. Generation and some reactions of polyfluorinated fluorenyl cations. J. Org. Chem. USSR 1978, 14, 559–565, (English Translation). [Google Scholar] [CrossRef]
  20. Marchetti, F.; Masi, F.; Pampaloni, G.; Passarelli, V.; Sommazzi, A.; Spera, S. Synthesis, variable temperature NMR investigations and solid state characterization of novel octafluorofluorene compounds. J. Fluor. Chem. 2009, 130, 341–347. [Google Scholar] [CrossRef]
  21. Mezhenkova, T.V.; Karpov, V.M.; Zonov, Y.V. Formation of polyfluorofluorenes in the reactions of perfluoro-1,1-diphenylalkanes with antimony pentafluoride. J. Fluor. Chem. 2018, 207, 59–66. [Google Scholar] [CrossRef]
  22. Mezhenkova, T.V.; Komarov, V.V.; Karpov, V.M.; Beregovaya, I.V.; Zonov, Y.V. Synthesis of 1-(tetrafluorophenyl)perfluoro-1-phenylethanes and their cyclization into polyfluoro-9-methylfluorenes under the action of antimony pentafluoride. J. Fluor. Chem. 2020, 237, 109615. [Google Scholar] [CrossRef]
  23. Komarov, V.V.; Mezhenkova, T.V.; Karpov, V.M.; Zonov, Y.V.; Krasnov, V.I. Formation of polyfluoro-1-ethylfluorenes in the reaction of perfluoropropylbenzene with tetrafluorobenzenes in an SbF5 medium. J. Fluor. Chem. 2023, 271, 110186. [Google Scholar] [CrossRef]
  24. Mezhenkova, T.V.; Komarov, V.V.; Karpov, V.M.; Zonov, Y.V.; Gatilov, Y.V. Reaction of perfluorotetralin with 1,2,3,4-tetrafluorobenzene in SbF5 medium: The formation of polycyclic compounds with a new carbon framework. J. Fluor. Chem. 2021, 250, 109882. [Google Scholar] [CrossRef]
  25. Karpov, V.M.; Mezhenkova, T.V.; Platonov, V.E.; Yakobson, G.G. Interaction of perfluorobenzocycloalkenes with tetrafluoroethylene in the presence of SbF5. J. Fluor. Chem. 1985, 28, 121–137. [Google Scholar] [CrossRef]
Scheme 1. Synthesis of the title compound.
Scheme 1. Synthesis of the title compound.
Molbank 2024 m1842 sch001
Scheme 2. Suggested reaction pathway.
Scheme 2. Suggested reaction pathway.
Molbank 2024 m1842 sch002
Figure 1. 2D NMR correlations for trans-3; depicted by arrows are some of the cross peaks observed in the following 2D NMR spectra: (a) 19F–19F COSY; (b) 19F–19F NOESY.
Figure 1. 2D NMR correlations for trans-3; depicted by arrows are some of the cross peaks observed in the following 2D NMR spectra: (a) 19F–19F COSY; (b) 19F–19F NOESY.
Molbank 2024 m1842 g001
Figure 2. 2D NMR correlations for cis-3; depicted by arrows are some of the cross peaks observed in the following 2D NMR spectra: (a) 19F–19F COSY; (b) 19F–19F NOESY.
Figure 2. 2D NMR correlations for cis-3; depicted by arrows are some of the cross peaks observed in the following 2D NMR spectra: (a) 19F–19F COSY; (b) 19F–19F NOESY.
Molbank 2024 m1842 g002
Figure 3. Sections of variable-temperature 19F NMR spectra of cis-3 showing the tertiary fluorine atoms.
Figure 3. Sections of variable-temperature 19F NMR spectra of cis-3 showing the tertiary fluorine atoms.
Molbank 2024 m1842 g003
Figure 4. Atom numbering scheme of compound 3.
Figure 4. Atom numbering scheme of compound 3.
Molbank 2024 m1842 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Komarov, V.V.; Krasnov, V.I.; Karpov, V.M.; Parkhomenko, D.A.; Mezhenkova, T.V. Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene. Molbank 2024, 2024, M1842. https://doi.org/10.3390/M1842

AMA Style

Komarov VV, Krasnov VI, Karpov VM, Parkhomenko DA, Mezhenkova TV. Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene. Molbank. 2024; 2024(3):M1842. https://doi.org/10.3390/M1842

Chicago/Turabian Style

Komarov, Vladislav V., Vyacheslav I. Krasnov, Victor M. Karpov, Dmitriy A. Parkhomenko, and Tatyana V. Mezhenkova. 2024. "Perfluoro-3-ethyl-1,2,3,10b-tetrahydrofluoranthene" Molbank 2024, no. 3: M1842. https://doi.org/10.3390/M1842

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop